PL2405892T3 - Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego - Google Patents

Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego

Info

Publication number
PL2405892T3
PL2405892T3 PL10701698T PL10701698T PL2405892T3 PL 2405892 T3 PL2405892 T3 PL 2405892T3 PL 10701698 T PL10701698 T PL 10701698T PL 10701698 T PL10701698 T PL 10701698T PL 2405892 T3 PL2405892 T3 PL 2405892T3
Authority
PL
Poland
Prior art keywords
ketoprophene
hydroxytic
pharmaceutical preparation
preparation containing
polyoxyalkylene ester
Prior art date
Application number
PL10701698T
Other languages
English (en)
Inventor
Michele Virno
Original Assignee
Lectio Pharmaentwicklungs Und Verwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lectio Pharmaentwicklungs Und Verwertungs Gmbh filed Critical Lectio Pharmaentwicklungs Und Verwertungs Gmbh
Publication of PL2405892T3 publication Critical patent/PL2405892T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL10701698T 2009-03-12 2010-02-02 Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego PL2405892T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09155046 2009-03-12
EP10701698A EP2405892B1 (en) 2009-03-12 2010-02-02 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
PCT/EP2010/051222 WO2010102862A1 (en) 2009-03-12 2010-02-02 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid

Publications (1)

Publication Number Publication Date
PL2405892T3 true PL2405892T3 (pl) 2013-10-31

Family

ID=40549651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10701698T PL2405892T3 (pl) 2009-03-12 2010-02-02 Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego

Country Status (18)

Country Link
EP (1) EP2405892B1 (pl)
AU (1) AU2010223495B2 (pl)
BR (1) BRPI1008983A2 (pl)
CA (1) CA2752713C (pl)
CL (1) CL2011002225A1 (pl)
CY (1) CY1114036T1 (pl)
DK (1) DK2405892T3 (pl)
EA (1) EA019992B1 (pl)
ES (1) ES2403380T3 (pl)
HR (1) HRP20130304T1 (pl)
IL (1) IL214676A (pl)
MX (1) MX2011009509A (pl)
NZ (1) NZ594646A (pl)
PL (1) PL2405892T3 (pl)
PT (1) PT2405892E (pl)
SI (1) SI2405892T1 (pl)
SM (1) SMT201300035B (pl)
WO (1) WO2010102862A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116637069B (zh) * 2023-07-19 2023-09-19 成都金瑞基业生物科技有限公司 一种和厚朴酚脂质体透皮凝胶剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (pl) * 1982-10-07 1986-05-15
DE19536244A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung zur lokalen Applikation
IT1270678B (it) 1994-10-20 1997-05-07 Bayer Ag Liposomi al chetoprofen
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
IT1277430B1 (it) * 1995-08-03 1997-11-10 Bayer Italia Spa Preparazioni farmaceutiche per uso topico a base di ketoprofene
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
US6083996A (en) 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
WO2010102862A1 (en) 2010-09-16
NZ594646A (en) 2013-12-20
CA2752713C (en) 2017-01-03
IL214676A (en) 2014-09-30
PT2405892E (pt) 2013-04-15
CL2011002225A1 (es) 2012-07-13
DK2405892T3 (da) 2013-04-08
EA019992B1 (ru) 2014-07-30
EP2405892B1 (en) 2013-01-16
AU2010223495A1 (en) 2011-09-08
CA2752713A1 (en) 2010-09-16
SMT201300035B (it) 2013-07-09
BRPI1008983A2 (pt) 2016-03-22
ES2403380T3 (es) 2013-05-17
EA201171124A1 (ru) 2012-02-28
CY1114036T1 (el) 2016-07-27
IL214676A0 (en) 2011-09-27
MX2011009509A (es) 2012-01-20
AU2010223495B2 (en) 2014-12-18
HRP20130304T1 (en) 2013-05-31
EP2405892A1 (en) 2012-01-18
SI2405892T1 (sl) 2013-06-28

Similar Documents

Publication Publication Date Title
PL2395991T3 (pl) Zastosowanie estru etylowego kwasu eikozapentaenowego do leczenia hipertriglicerydemii
SMT201400069B (it) Formulazione farmaceutica
IL250259A0 (en) Compositions comprising ursolic acid and derivatives thereof and uses thereof
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
IL245328A0 (en) Pharmaceutical composition
BR112013013663A2 (pt) ácidos 1-benzilcicloalquilcarboxílicos substituídos e sua utilização
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
PL3590949T3 (pl) Kwasy rybonukleinowe zawierające n1-metylo-pseudouracyle i ich zastosowania
BR112012014962A2 (pt) métodos e composições para formulações líquidas e estáveis de fármacos
IL224564A (en) Derivatives of esters of cyclic boronic acids and their medicinal uses
EP2616076A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2451274A4 (en) Pharmaceutical compositions
GT201200303A (es) Formulaciones farmacéuticas
BRPI0921654A2 (pt) formulação farmacêutica
PL2651409T3 (pl) Nowa kompozycja farmaceutyczna zawierająca nlpz i cyklodekstrynę
ZA201204414B (en) Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
PL2427417T3 (pl) Sole kwasu 3-pentylofenylooctowego i ich farmaceutyczne zastosowania
BRPI0922653A2 (pt) preparação farmacêutica
BRPI1007194A2 (pt) Composição compreendendo ácido chicórico e/ou derivados do mesmo
BR112013005376A2 (pt) conjugados de ácidos graxos poli-insaturados e compostos contendo aminas e usos dos mesmos
IL226003A0 (en) Derivation of trans-2-decenoic acid and a pharmaceutical agent containing it
BR112012015016A2 (pt) formulação farmacèutica e forma de dosagem farmacêutica entérica
EP2548872A4 (en) Cyclopropanecarboxylate DERIVATIVE
BRPI0912656A2 (pt) formulação farmacêutica sólida